valine has been researched along with 2019 Novel Coronavirus Disease in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 14 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsanni, A | 1 |
| Abbaspour Kasgari, H; Abdollahi, M; Abedi, F; Afshari, M; Akbarpour, E; Ali Asgari, A; Anushiravani, A; Arizavi, Z; Azarkar, Z; Azimi, E; Babamahmoodi, F; Bahadori, AR; Barahimi, E; Bonyadi, A; Davoodi, L; Davoudi Badabi, AR; Dehghan Manshadi, SA; Dehghani, F; Ebrahimzadeh, A; Ebrahimzadeh, M; Eslami, G; Esmaeilian, H; Fakheri, H; Hasooni Bahrini, N; Hassaniazad, M; Hill, A; Hormati, A; Hosamirudsari, H; Jelvay, S; Joukar, F; Karimi, J; Khajavirad, N; Khodadadi, J; Levi, J; Mansour-Ghanaei, F; McCann, K; Mehrabi, Z; Merat, D; Merat, S; Mirzaei, H; Mobarak, M; Mobarak, S; Moghimi, M; Moslemi, R; Mousavi, H; Mousaviasl, S; Naghipour, M; Nateghi Baygi, A; Nateghi Baygi, H; Nekoukar, Z; Noori Jangi, M; Poormontaseri, Z; Pourmasoomi, H; Radmanesh, E; Rezaie Keikhaie, L; Sadeghi, A; Salasi, M; Salehi, M; Salmanzadeh, S; Sayar, S; Shabani, AM; Shabani, M; Shokouhi, S; Simmons, B; Tousi, A; Wentzel, H; Yaghoubi, S; Yaghubi Kalurazi, T; Yeganeh, S; Zeinali, A; Ziaee, M; Zolfaghari, F | 1 |
| Bozza, PT; Chaves, OA; Chien, M; Fintelman-Rodrigues, N; Garzia, A; Jockusch, S; Ju, J; Kumar, S; Li, X; Meyer, C; Patel, DJ; Russo, JJ; Sacramento, CQ; Souza, TML; Tao, C; Temerozo, JR; Tuschl, T; Wang, X; Xie, W | 1 |
| Kim, B; Park, C; Park, T | 1 |
| Liao, L; Liu, Q; Wang, Y; Zhang, J | 1 |
| Akpomiemie, G; Bosch, B; Casas, CP; Ellis, L; Hill, A; Johnstone, H; Owen, A; Simmons, B; Sokhela, S; Venter, WDF; Woods, J | 1 |
| Abbaspour Kasgari, H; Alikhani, A; Babamahmoodi, F; Davoudi Badabi, AR; Davoudi, L; Garratt, A; Hedayatizadeh Omran, A; Hill, A; Levi, J; Merat, S; Moradi, S; Saeedi, M; Shabani, AM; Simmons, B; Tirgar Fakheri, H; Wentzel, H | 1 |
| Afhami, S; Akbarpour, E; Ali Asgari, A; Aliannejad, R; Anushirvani, A; Davarpanah, AH; Garratt, A; Hill, A; Hosamirudsai, H; Kheiri, Z; Levi, J; Merat, S; Montazeri, M; Norouzi, A; Qavi, A; Radmard, AR; Sadeghi, A; Simmons, B; Wentzel, H | 1 |
| Bitaraf, S; Eslami, G; Esmaeilian, H; Freeman, J; Hajizadeh Farsani, M; Hill, A; Jafari Kashi, AH; Jelvay, S; Lotfi, Z; Marjani, S; Mobarak, M; Mobarak, S; Momtazan, M; Mousaviasl, S; Radmanesh, E; Sadeghi, A; Salmanzadeh, S; Simmons, B; Tabibi, R; Talebzadeh, SM; Wentzel, H; Wickramatillake, A | 1 |
| Alizadeh-Navaei, R; Hedayatizadeh-Omran, A; Hill, A; Levi, J; Merat, S; Roozbeh, F; Saeedi, M; Shamshirian, A; Wentzel, H | 1 |
| Chan, HT; Chao, CM; Lai, CC | 1 |
| Bastos, MM; Boechat, N; Bou-Habib, DC; Bozza, FA; Bozza, PT; Branco, FSC; Chien, M; Da Silva, APD; da Silva, CDS; de Freitas, CS; Dias, SDSG; Fernandes, TVA; Ferreira, AC; Ferreira, MA; Fintelman-Rodrigues, N; Garzia, A; Goto-Silva, L; Guimarães, MZ; Hoelz, LVB; Jockusch, S; Ju, J; Mattos, M; Owen, A; Pão, CRR; Patel, D; Pedrosa, CSG; Rajoli, RKR; Rehen, SK; Russo, JJ; Sacramento, CQ; Saraiva, FB; Soares, VC; Souza, LRQ; Souza, TML; Tao, C; Temerozo, JR; Tuschl, T; Vitória, G; Wang, X; Xie, W | 1 |
| Chodosh, J; Cui, L; Dai, R; Lan, Q; Lan, W; Lu, L; Ou, J; Ren, Y; Seto, D; Wu, J; Wu, X; Zhang, G; Zhang, J; Zhang, Q; Zhao, S; Zhou, Z | 1 |
| Abd Elghafar, M; Abd-Elsalam, S; AbdAllah, M; Cordie, A; El-Akel, W; El-Badrawy, A; El-Bendary, M; El-Shazly, M; Elalfy, H; Elbaz, T; Elegezy, M; Elhadidy, T; Esmat, G; Essam, M; Farid, K; Neamatallah, M; Salama, M | 1 |
7 trial(s) available for valine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER).
Topics: Adult; Antiviral Agents; Carbamates; COVID-19; Humans; Imidazoles; Pyrrolidines; SARS-CoV-2; Sofosbuvir; Treatment Outcome; Valine | 2022 |
Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection.
Topics: Antiviral Agents; Carbamates; COVID-19; Humans; Imidazoles; Nitro Compounds; Pyrrolidines; SARS-CoV-2; Sofosbuvir; South Africa; Thiazoles; Treatment Outcome; Valine | 2022 |
Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial.
Topics: Adult; Aged; Antiviral Agents; Betacoronavirus; Carbamates; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Female; Hospitalization; Humans; Imidazoles; Iran; Male; Middle Aged; Pandemics; Pneumonia, Viral; Pyrrolidines; Ribavirin; SARS-CoV-2; Sofosbuvir; Treatment Outcome; Valine | 2020 |
Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial.
Topics: Adult; Aged; Antiviral Agents; Betacoronavirus; Carbamates; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Female; Humans; Imidazoles; Iran; Male; Middle Aged; Pandemics; Patient Admission; Pneumonia, Viral; Pyrrolidines; SARS-CoV-2; Severity of Illness Index; Sofosbuvir; Treatment Outcome; Valine | 2020 |
The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19.
Topics: Adult; Aged; Antiviral Agents; Betacoronavirus; Carbamates; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Female; Humans; Imidazoles; Male; Middle Aged; Pandemics; Pneumonia, Viral; Pyrrolidines; Ribavirin; SARS-CoV-2; Sofosbuvir; Treatment Outcome; Valine | 2020 |
Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial.
Topics: Adult; Ambulatory Care; Antimalarials; Antiviral Agents; Carbamates; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Imidazoles; Male; Middle Aged; Pyrrolidines; Sofosbuvir; Treatment Outcome; Valine | 2021 |
Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.
Topics: Antiviral Agents; Carbamates; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Egypt; Humans; Imidazoles; Length of Stay; Prospective Studies; Pyrrolidines; SARS-CoV-2; Sofosbuvir; Treatment Outcome; Valine | 2022 |
7 other study(ies) available for valine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
African scientists race to test COVID drugs - but face major hurdles.
Topics: Africa; Amides; Amodiaquine; Artesunate; Atazanavir Sulfate; Carbamates; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Cytidine; Drug Approval; Drug Evaluation, Preclinical; Drug Repositioning; Drug Therapy, Combination; Humans; Hydroxylamines; Imidazoles; Ivermectin; Naphthyridines; Nitro Compounds; Pregnenediones; Pyrazines; Pyrrolidines; Ritonavir; Sample Size; Thiazoles; Valine; World Health Organization | 2021 |
Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture.
Topics: Amino Acid Sequence; Anilides; Animals; Antiviral Agents; Base Sequence; Benzimidazoles; Cell Line, Tumor; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Drug Synergism; Exonucleases; Humans; Proline; Pyrrolidines; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2; Valine; Vero Cells; Viral Nonstructural Proteins; Virus Replication | 2022 |
DeepHisCoM: deep learning pathway analysis using hierarchical structural component models.
Topics: Biological Factors; Carcinoma, Hepatocellular; COVID-19; Deep Learning; Gonadotropin-Releasing Hormone; Humans; Isoleucine; Leucine; Liver Neoplasms; Lysine; Mitogen-Activated Protein Kinases; Phenylalanine; Tryptophan; Tyrosine; Valine | 2022 |
Why Omicron Variant of SARS-CoV-2 is Less Fatal?
Topics: COVID-19; Glycine; Humans; Lysine; SARS-CoV-2; Valine | 2022 |
Sofosbuvir/daclatasvir in the treatment of COVID-19 infection: A meta-analysis.
Topics: Antiviral Agents; Carbamates; China; COVID-19; Humans; Imidazoles; Pyrrolidines; SARS-CoV-2; Sofosbuvir; Valine | 2021 |
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19.
Topics: Animals; Antiviral Agents; Carbamates; Chlorocebus aethiops; COVID-19; Humans; Imidazoles; Pharmaceutical Preparations; Pyrrolidines; RNA, Viral; SARS-CoV-2; Sofosbuvir; Valine; Vero Cells | 2021 |
V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
Topics: Amino Acid Substitution; Angiotensin-Converting Enzyme 2; Binding Sites; COVID-19; Gene Expression; Host-Pathogen Interactions; Humans; Kinetics; Molecular Dynamics Simulation; Mutation; Phenylalanine; Phylogeny; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Thermodynamics; Valine; Virulence; Virus Attachment | 2021 |